U.S. By

Daraxonrasib Pancreatic Cancer Pill: What the Early Trial Results Show

A once-daily pill taken alongside chemotherapy left tumors undetectable on scans in about one in 12 patients with advanced pancreatic cancer, according to early trial results reported by the BBC, LBC and Cambridge News. Researchers say the findings are promising but small, and they stress the result is not a cure.

The drug, daraxonrasib, targets a mutated gene that drives most pancreatic tumors. The results were presented at a cancer research meeting in Barcelona.

The central numbers

The median follow-up was 18 months. Fewer than 5% of participants stopped treatment, which is regarded as low, Cambridge News reported.

How the drug works

Daraxonrasib is a KRAS inhibitor. It locks onto a mutated version of the KRAS gene, found in more than nine in 10 pancreatic tumors, which sends constant signals telling cancer cells to grow. Shutting that signal off can stop tumors from spreading, the reports say. The BBC reported that the drug has already been approved in the U.S. Cambridge News said it made global headlines in May after a study found it nearly doubled survival time compared with chemotherapy alone in aggressive, advanced disease.

Because similar mutations appear in dozens of other cancers, including lung and ovarian, the BBC reported that the drug might eventually help many more patients. Cancer Research UK's Dr. Sam Godfrey said he hopes early success in pancreatic cancer can be extended to other cancers.

What the researchers say

Dr. Wungki Park, an oncologist at Memorial Sloan Kettering Cancer Center in New York who presented the findings, told the Press Association it was “a massive, massive breakthrough.” Asked whether patients whose tumors vanished from scans were considered cured, he said it was “the closest to cure.” He added that longer-term survival data will come as the trial continues, and that cancer often develops resistance to drugs, which the combination aims to delay as long as possible.

Others urged caution. Pancreatic Cancer UK's Dr. Madina Kara called the study small and at an early stage, though encouraging. Cancer Research UK chief executive Michelle Mitchell described the results as the biggest leap forward in decades for pancreatic cancer patients, but said survival remains very low and more trials are needed. The BBC noted that doctors cannot yet say how long the disease might be held at bay.

Why it matters

Pancreatic cancer is among the deadliest and hardest to treat. Chemotherapy can shrink tumors a little, but the disease often grows back, and most patients with advanced disease survive months rather than years, the BBC reported. In the United States, it accounts for about 3% of all cancers and about 8% of cancer deaths, killing around 53,000 people a year, according to the BBC. In Britain, Cancer Research UK counts 11,500 diagnoses and around 10,200 deaths a year.

For patients and families, the findings suggest the pill-plus-chemotherapy combination may offer more time and, in some cases, deeper responses than chemotherapy alone. Because the trial was small and early, it cannot yet show that.

What happens next

A phase three trial in the U.S. already has enough patients, Park said, though some European sites may still have space, Cambridge News reported. Experts say the combination must be tested in a larger trial before it can be assessed for use on Britain's National Health Service. Pancreatic Cancer UK called on the U.K. government to increase investment in research and clinical trials.

Around Prague, based on reporting by BBC, LBC, Cambridge News

Share: Telegram WhatsApp

More U.S. news

Toyota Recalls 314,029 Older Toyota and Lexus Vehicles Over Takata Airbag Risk
Toyota is recalling 314,029 Toyota and Lexus vehicles in the United States because the front passenger airbag inflators, made by Takata, could rupture in a crash and throw metal fragments at people in
Democrats Lock In a 56-Seat Senate Majority After Alaska Race Ends
Democrats will hold 56 seats in the Senate when the new Congress convenes next year, their largest majority in nearly two decades, the Guardian reported. The tally became official on Tuesday, when the
Qpancy Children's Pajama Sets Recalled Over Burn Risk
Qpancy is recalling about 1,309 children's pajama sets sold on Amazon.com because they violate mandatory U.S. safety standards for children's sleepwear, the U.S. Consumer Product Safety Commission ann
Michael LoSapio, Trump’s CISA Pick, Declines to Call Jan. 6 an Attack
Michael LoSapio, President Donald Trump’s nominee to lead the Cybersecurity and Infrastructure Security Agency, told senators Thursday that he does not consider the Jan. 6, 2021, riot at the U.S. Capi
CHE-US Magnetic Robot Toys Recall: Magnets Can Come Loose From Figures
CHE-US is recalling its magnetic robot-shaped stick figure toys in the United States because small, high-powered magnets can come out of them and be swallowed by children, the U.S. Consumer Product Sa
Patrick Stewart’s Death Certificate Names Cardiac Arrest and Lewy Body Disorder
Patrick Stewart’s death certificate lists cardiopulmonary arrest and a neurocognitive disorder with Lewy body as his cause of death, according to documents obtained by TMZ and relayed by The Independe

Related news

Toyota is recalling 314,029 Toyota and Lexus vehicles in the United States because the front passenger airbag inflators, made by Takata, could rupture in a crash and throw metal fragments at people inside, according to a report filed with t
Democrats will hold 56 seats in the Senate when the new Congress convenes next year, their largest majority in nearly two decades, the Guardian reported. The tally became official on Tuesday, when the long ballot count in Alaska ended with
Qpancy is recalling about 1,309 children's pajama sets sold on Amazon.com because they violate mandatory U.S. safety standards for children's sleepwear, the U.S. Consumer Product Safety Commission announced on Nov. 19. The agency said the s
Michael LoSapio, President Donald Trump’s nominee to lead the Cybersecurity and Infrastructure Security Agency, told senators Thursday that he does not consider the Jan. 6, 2021, riot at the U.S. Capitol an attack. He also refused to say wh
CHE-US is recalling its magnetic robot-shaped stick figure toys in the United States because small, high-powered magnets can come out of them and be swallowed by children, the U.S. Consumer Product Safety Commission (CPSC) said in a notice
Patrick Stewart’s death certificate lists cardiopulmonary arrest and a neurocognitive disorder with Lewy body as his cause of death, according to documents obtained by TMZ and relayed by The Independent, E! News and the Los Angeles Times. S
Hultafors Group North America is recalling about 229,430 trade tools in the United States because their button cell batteries can be reached easily by children, the U.S. Consumer Product Safety Commission (CPSC) said in a notice dated Nov.
President Donald Trump announced Thursday that he has pardoned Pete Rose, baseball's career hits leader, more than two years after Rose's death, according to ABC News, NBC News and Fox News. Rose died in 2024 at age 83. Trump made the annou
Fiona, the Cincinnati Zoo hippo whose story of surviving a premature birth made her one of America's best-known zoo animals, has died. The Cincinnati Zoo & Botanical Garden announced the news Thursday, saying she did not recover after s
The Dow lost 1,101 points and closed below 50,000, and the S&P 500 fell for a sixth straight day. Fed rate-hike fears, money rotating into Anthropic and a short report on AMD drove the sell-off. Bitcoin touched about $61,700.
The leaders of the United States, China and Russia held an unprecedented three-way summit in the Chinese tech hub of Shenzhen on Thursday, on the sidelines of the Asia-Pacific Economic Cooperation (APEC) gathering. President Donald Trump, C
JPMorgan Chase, Visa and Mastercard said Thursday that cyberattacks on outside vendors exposed some customer data, with Chase saying the attackers reached marketing data such as names and email addresses. All three companies said payment de